1. Home
  2. KALV vs PSIX Comparison

KALV vs PSIX Comparison

Compare KALV & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

PSIX

Power Solutions International Inc.

HOLD

Current Price

$40.65

Market Cap

960.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
PSIX
Founded
N/A
1985
Country
United States
United States
Employees
N/A
1000
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
960.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
PSIX
Price
$26.99
$40.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$32.60
$99.95
AVG Volume (30 Days)
3.0M
697.4K
Earning Date
07-09-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
$24.73
Revenue Next Year
$59.23
$16.20
P/E Ratio
N/A
$17.20
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$35.77
52 Week High
$27.00
$121.47

Technical Indicators

Market Signals
Indicator
KALV
PSIX
Relative Strength Index (RSI) 75.79 40.86
Support Level $14.22 $35.77
Resistance Level N/A $44.26
Average True Range (ATR) 0.03 2.60
MACD -0.23 1.00
Stochastic Oscillator 95.83 48.43

Price Performance

Historical Comparison
KALV
PSIX

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States, and also has its presence in North America (outside of United States), Pacific Rim, Europe and Others.

Share on Social Networks: